153 related articles for article (PubMed ID: 28818080)
1. Standardized, systemic phenotypic analysis reveals kidney dysfunction as main alteration of Kctd1
Kumar S; Rathkolb B; Sabrautzki S; Krebs S; Kemter E; Becker L; Beckers J; Bekeredjian R; Brommage R; Calzada-Wack J; Garrett L; Hölter SM; Horsch M; Klingenspor M; Klopstock T; Moreth K; Neff F; Rozman J; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Wolf E; Aigner B
J Biomed Sci; 2017 Aug; 24(1):57. PubMed ID: 28818080
[TBL] [Abstract][Full Text] [Related]
2. Generation and Standardized, Systemic Phenotypic Analysis of Pou3f3L423P Mutant Mice.
Kumar S; Rathkolb B; Kemter E; Sabrautzki S; Michel D; Adler T; Becker L; Beckers J; Busch DH; Garrett L; Hans W; Hölter SM; Horsch M; Klingenspor M; Klopstock T; Rácz I; Rozman J; Vargas Panesso IL; Vernaleken A; Zimmer A; Fuchs H; Gailus-Durner V; Hrabě de Angelis M; Wolf E; Aigner B
PLoS One; 2016; 11(3):e0150472. PubMed ID: 27003440
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the scalp-ear-nipple syndrome unraveled by the characterization of disease-causing KCTD1 mutants.
Smaldone G; Balasco N; Pirone L; Caruso D; Di Gaetano S; Pedone EM; Vitagliano L
Sci Rep; 2019 Jul; 9(1):10519. PubMed ID: 31324836
[TBL] [Abstract][Full Text] [Related]
4. Mutations in KCTD1 cause scalp-ear-nipple syndrome.
Marneros AG; Beck AE; Turner EH; McMillin MJ; Edwards MJ; Field M; de Macena Sobreira NL; Perez AB; Fortes JA; Lampe AK; Giovannucci Uzielli ML; Gordon CT; Plessis G; Le Merrer M; Amiel J; Reichenberger E; Shively KM; Cerrato F; Labow BI; Tabor HK; Smith JD; Shendure J; Nickerson DA; Bamshad MJ;
Am J Hum Genet; 2013 Apr; 92(4):621-6. PubMed ID: 23541344
[TBL] [Abstract][Full Text] [Related]
5. KCTD1 mutants in scalp‑ear‑nipple syndrome and AP‑2α P59A in Char syndrome reciprocally abrogate their interactions, but can regulate Wnt/β‑catenin signaling.
Hu L; Chen L; Yang L; Ye Z; Huang W; Li X; Liu Q; Qiu J; Ding X
Mol Med Rep; 2020 Nov; 22(5):3895-3903. PubMed ID: 33000225
[TBL] [Abstract][Full Text] [Related]
6. Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models.
Aigner B; Rathkolb B; Herbach N; Kemter E; Schessl C; Klaften M; Klempt M; de Angelis MH; Wanke R; Wolf E
Am J Physiol Renal Physiol; 2007 May; 292(5):F1560-7. PubMed ID: 17264314
[TBL] [Abstract][Full Text] [Related]
7. Distinct Morphological and Behavioural Alterations in ENU-Induced Heterozygous
Rathkolb B; Howaldt M; Krebs S; Prückl P; Sauer S; Hrabě de Angelis M; Aigner B
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828338
[No Abstract] [Full Text] [Related]
8. Large-scale albuminuria screen for nephropathy models in chemically induced mouse mutants.
Rathkolb B; Tran TV; Klempt M; Hrabé de Angelis M; Wanke R; Wolf E; Aigner B
Nephron Exp Nephrol; 2005; 100(4):e143-9. PubMed ID: 15849479
[TBL] [Abstract][Full Text] [Related]
9.
Wang D; Trevillian P; May S; Diakumis P; Wang Y; Colville D; Bahlo M; Greferath U; Fletcher E; Young B; Mack HG; Savige J
Ophthalmic Genet; 2023 Feb; 44(1):19-27. PubMed ID: 36579937
[TBL] [Abstract][Full Text] [Related]
10. Characterization and expression of a human KCTD1 gene containing the BTB domain, which mediates transcriptional repression and homomeric interactions.
Ding XF; Luo C; Ren KQ; Zhang J; Zhou JL; Hu X; Liu RS; Wang Y; Gao X; Zhang J
DNA Cell Biol; 2008 May; 27(5):257-65. PubMed ID: 18358072
[TBL] [Abstract][Full Text] [Related]
11. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.
Kemter E; Prueckl P; Sklenak S; Rathkolb B; Habermann FA; Hans W; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R
Hum Mol Genet; 2013 Oct; 22(20):4148-63. PubMed ID: 23748428
[TBL] [Abstract][Full Text] [Related]
12. Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models.
Aigner B; Rathkolb B; Klaften M; Sedlmeier R; Klempt M; Wagner S; Michel D; Mayer U; Klopstock T; de Angelis MH; Wolf E
Exp Physiol; 2009 Apr; 94(4):412-21. PubMed ID: 19151073
[TBL] [Abstract][Full Text] [Related]
13. Standardized, systemic phenotypic analysis of Umod(C93F) and Umod(A227T) mutant mice.
Kemter E; Prückl P; Rathkolb B; Micklich K; Adler T; Becker L; Beckers J; Busch DH; Götz AA; Hans W; Horsch M; Ivandic B; Klingenspor M; Klopstock T; Rozman J; Schrewe A; Schulz H; Fuchs H; Gailus-Durner V; Hrabé de Angelis M; Wolf E; Aigner B
PLoS One; 2013; 8(10):e78337. PubMed ID: 24205203
[TBL] [Abstract][Full Text] [Related]
14. Scalp-Ear-Nipple syndrome: first report of a Potassium channel tetramerization domain-containing 1 in-frame insertion and review of the literature.
Butler KM; Bahrambeigi V; Merrihew A; Friez MJ; Cathey SS
Clin Dysmorphol; 2021 Oct; 30(4):167-172. PubMed ID: 34456244
[TBL] [Abstract][Full Text] [Related]
15. The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations.
Fuchs H; Sabrautzki S; Przemeck GK; Leuchtenberger S; Lorenz-Depiereux B; Becker L; Rathkolb B; Horsch M; Garrett L; Östereicher MA; Hans W; Abe K; Sagawa N; Rozman J; Vargas-Panesso IL; Sandholzer M; Lisse TS; Adler T; Aguilar-Pimentel JA; Calzada-Wack J; Ehrhard N; Elvert R; Gau C; Hölter SM; Micklich K; Moreth K; Prehn C; Puk O; Racz I; Stoeger C; Vernaleken A; Michel D; Diener S; Wieland T; Adamski J; Bekeredjian R; Busch DH; Favor J; Graw J; Klingenspor M; Lengger C; Maier H; Neff F; Ollert M; Stoeger T; Yildirim AÖ; Strom TM; Zimmer A; Wolf E; Wurst W; Klopstock T; Beckers J; Gailus-Durner V; Hrabé de Angelis M
G3 (Bethesda); 2016 Dec; 6(12):4035-4046. PubMed ID: 27815347
[TBL] [Abstract][Full Text] [Related]
16. Standardized, systemic phenotypic analysis of Slc12a1I299F mutant mice.
Kemter E; Rathkolb B; Becker L; Bolle I; Busch DH; Dalke C; Elvert R; Favor J; Graw J; Hans W; Ivandic B; Kalaydjiev S; Klopstock T; Rácz I; Rozman J; Schrewe A; Schulz H; Zimmer A; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Wolf E; Aigner B
J Biomed Sci; 2014 Aug; 21(1):68. PubMed ID: 25084970
[TBL] [Abstract][Full Text] [Related]
17. Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in hematological parameters.
Aigner B; Rathkolb B; Klempt M; Wagner S; Michel D; Klaften M; Laufs J; Schneider B; Sedlmeier R; Hrabé de Angelis M; Wolf E
Mamm Genome; 2011 Oct; 22(9-10):495-505. PubMed ID: 21553221
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and pathomorphological characteristics of a novel mutant mouse model for maturity-onset diabetes of the young type 2 (MODY 2).
van Bürck L; Blutke A; Kautz S; Rathkolb B; Klaften M; Wagner S; Kemter E; Hrabé de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E512-23. PubMed ID: 19952346
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.
Srivastava AK; Kapur S; Mohan S; Yu H; Kapur S; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Jun; 20(6):1041-50. PubMed ID: 15883645
[TBL] [Abstract][Full Text] [Related]
20. A new Fgf10 mutation in the mouse leads to atrophy of the harderian gland and slit-eye phenotype in heterozygotes: a novel model for dry-eye disease?
Puk O; Esposito I; Söker T; Löster J; Budde B; Nürnberg P; Michel-Soewarto D; Fuchs H; Wolf E; Hrabé de Angelis M; Graw J
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4311-8. PubMed ID: 19407009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
